ORBIMED ADVISORS LLC
124 holdingsFiling period: 2026-06-30Current AUM: $5.20Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | EWTX | EDGEWISE THERAPEUTICS INC | 15.52M | $630.5M | $677.1M | 13.02% | -- | 2026-06-30 |
| 2 | ELVN | ENLIVEN THERAPEUTICS INC | 6.78M | $343.9M | $361.6M | 6.95% | -1,182,906 | 2026-06-30 |
| 3 | LLY | ELI LILLY & CO | 257.9K | $309.3M | $293.0M | 5.63% | +21.1K | 2026-06-30 |
| 4 | MBX | MBX BIOSCIENCES INC | 3.43M | $189.3M | $209.4M | 4.03% | -209,151 | 2026-06-30 |
| 5 | — | SINOVAC BIOTECH LTD | 2.72M | $184.5M | $184.5M | 3.55% | -- | 2026-06-30 |
| 6 | — | ASTRAZENECA PLC | 915.7K | $171.1M | $171.1M | 3.29% | +245.5K | 2026-06-30 |
| 7 | GPCR | STRUCTURE THERAPEUTICS INC | 2.21M | $118.6M | $86.1M | 1.65% | +734.0K | 2026-06-30 |
| 8 | SION | SIONNA THERAPEUTICS INC | 2.56M | $112.4M | $17.6M | 0.34% | -974,825 | 2026-06-30 |
| 9 | CRVS | CORVUS PHARMACEUTICALS INC | 7.17M | $107.0M | $92.8M | 1.78% | -- | 2026-06-30 |
| 10 | AVBP | ARRIVENT BIOPHARMA INC | 3.03M | $105.2M | $84.7M | 1.63% | -- | 2026-06-30 |
| 11 | ABVX | ABIVAX SA | 746.5K | $99.5M | $79.6M | 1.53% | +280.8K | 2026-06-30 |
| 12 | GH | GUARDANT HEALTH INC | 583.7K | $87.6M | $102.5M | 1.97% | +148.5K | 2026-06-30 |
| 13 | ARGX | ARGENX SE | 92.9K | $86.2M | $91.0M | 1.75% | -44,020 | 2026-06-30 |
| 14 | MRK | MERCK & CO INC | 663.4K | $85.2M | $95.4M | 1.83% | -- | 2026-06-30 |
| 15 | — | UNIQURE NV | 1.81M | $83.3M | $83.3M | 1.60% | -328,663 | 2026-06-30 |
| 16 | PRAX | PRAXIS PRECISION MEDICINES I | 230.1K | $77.0M | $72.0M | 1.38% | +57.6K | 2026-06-30 |
| 17 | EW | EDWARDS LIFESCIENCES CORP | 834.9K | $75.5M | $71.6M | 1.38% | -395,700 | 2026-06-30 |
| 18 | PRLD | PRELUDE THERAPEUTICS INC | 13.72M | $73.2M | $62.0M | 1.19% | +2.82M | 2026-06-30 |
| 19 | DYN | DYNE THERAPEUTICS INC | 3.24M | $71.9M | $57.9M | 1.11% | +317.8K | 2026-06-30 |
| 20 | NTRA | NATERA INC | 262.0K | $71.1M | $91.9M | 1.77% | -- | 2026-06-30 |
| 21 | UNH | UNITEDHEALTH GROUP INC | 171.1K | $71.1M | $64.3M | 1.24% | -- | 2026-06-30 |
| 22 | CGON | CG ONCOLOGY INC | 972.8K | $69.1M | $70.6M | 1.36% | +24.5K | 2026-06-30 |
| 23 | SPRY | ARS PHARMACEUTICALS INC | 8.29M | $66.4M | $35.2M | 0.68% | -- | 2026-06-30 |
| 24 | — | ASCENDIS PHARMA A/S | 244.5K | $65.2M | $65.2M | 1.25% | -- | 2026-06-30 |
| 25 | HUM | HUMANA INC | 164.1K | $65.2M | $65.1M | 1.25% | -- | 2026-06-30 |
← Scroll →
Page 1 of 5